VANECK ETF TRUST - PHARMACEUTCL ETF (PPH)

CUSIP: 92189F692

Q4 2019 13F Holders as of 31 Dec 2019

Share change
+161,798
Put/Call ratio
68%
SEC-reported price per share
$64.18
Number of holders
48
Value change
+$10,968,047
Number of buys
14
Open additional details 1 more signal available
Number of sells
18

Security key

92189F692

Report period

Q4 2019

Institutions

48

Top holders

10

Ownership snapshot

Top reported holders of PPH - VANECK ETF TRUST - PHARMACEUTCL ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Disclosed value leader
Comparable rows
0/0
Latest evidence
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

13F holder rows

Institutional holders as of Q4 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
48
Shares
3,207,826
Rows available
48
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders
43
Q4 2019 holders
48
Holder diff
5
Investor Q3 2019 Shares Q4 2019 Shares Share Diff Share Chg % Q3 2019 value Q4 2019 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .